The Bioguard “VLabs 4BX” Test |
The Vlabs 4BX is a test developed by Bioguard Corporation for the detection of 4 vector-borne diseases (CVBD) in dogs' blood. Vector-borne diseases are a growing global threat, it’s one of "a group of globally distributed and rapidly spreading illnesses that are caused by a range of pathogens transmitted by arthropods including ticks, fleas, mosquitoes, and sandflies.
Many CVBD are transmissible to humans as well as companion animals. Some CVBD’s are fatal; most can only be controlled, not cured. Since some of the CVBD’s may have high occurrence or very low occurrence in a certain specific region, Bioguard Corporation unlike other suppliers in the market, offers more flexibility in testing CVBD’s by providing several options of the CVBD tests in order to give you the diagnostic flexibility to meet the individual needs of your region.
The VLabs 4BX is designed to detect: Heartworm, Anaplasma, B. Gibsoni, Ehrlichia canis. It is so far the only in-clinic diagnostic test that provides the Babesia Gibsoni alongside the other diseases in CVBD’s rapid test kit. To know more about Bioguard product list please click here |
Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) |
Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) are both retroviruses that vitally affect domestic cat populations. Although caused by distinct viruses, these diseases have similarities: both are contagious and incurable; both are more likely to be acquired by a cat that is allowed outside. Unlike some forms of viruses that infect cells and then kill them, FeLV and FIV actually alter the genetic material of the infected cell and turn cells into little virus factories. This process takes time, so in both cases, cats may be infected for many years before becoming clinically ill. FeLV and FIV in cats are serious and unfortunately incurable diseases, the best way to prevent the spread of these diseases is to have your cat tested regularly. The Bioguard VETlabs Feline leukemia Virus (FeLV) Ag/ Feline immunodeficiency Virus (FIV) Ab Combo Test is a sandwich lateral flow immunochromatographic assay, developed by Bioguard Corporation for enabling the simplicity of rapidly testing or detecting the feline leukemia virus antigen and feline immunodeficiency Virus antibody in cat’s blood. Read more |
| | Bioguard Participates the Healthcare+ Expo Taiwan |
The Bioguard participates the four- day event “Healthcare+ Expo Taiwan” on December 3- 7, 2020 in Nangang Exhibition Center, Taipei, Taiwan. |
The exhibition was participated by related government and private institutions in Taiwan, following the strict protocols for safety amidst pandemic.
Along with other booths, Bioguard has showcased our high-and-export quality products for the veterinary practice. We have also introduced our laboratory diagnostic services in our ISO certified diagnostic laboratory in Taipei. The said event has become a platform to bridge the gap between the healthcare biotechnology innovations and the people whom these are intended for. |
Rates of dog bite in children up during COVID-19 pandemic |
Aurora, Colo. (Aug. 11, 2020)-Greater rates of Colorado’s children are going to the pediatric emergency department as a result of dog bites during the COVID-19 pandemic, according to a recently published commentary article in the Journal of Pediatrics. The article’s authors, Cinnamon Dixon, DO, MPH/MSPH and Rakesh Mistry, MD/MS, who are attending physicians at Children’s Hospital Colorado (Children’s Colorado) and University of Colorado School of Medicine faculty, share data revealing significant increases in dog bite rates presenting to Children’s Colorado since the initiation of statewide stay-at-home orders in March. Moreover, high rates of dog bite injuries have continued even as these orders have relaxed over time. Read more |
|
